176 related articles for article (PubMed ID: 21047589)
1. Deciding on PSA-screening - Quality of current consumer information on the Internet.
Korfage IJ; van den Bergh RC; Essink-Bot ML
Eur J Cancer; 2010 Nov; 46(17):3073-81. PubMed ID: 21047589
[TBL] [Abstract][Full Text] [Related]
2. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
Yasunaga H; Sugihara T; Imamura T
Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
[TBL] [Abstract][Full Text] [Related]
3. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen testing and prostate cancer screening.
Djavan B; Eckersberger E; Finkelstein J; Sadri H; Taneja SS; Lepor H
Prim Care; 2010 Sep; 37(3):441-59, vii. PubMed ID: 20705192
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
7. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
[TBL] [Abstract][Full Text] [Related]
8. The impact of informed consent on patient interest in prostate-specific antigen screening.
Wolf AM; Nasser JF; Wolf AM; Schorling JB
Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
[TBL] [Abstract][Full Text] [Related]
9. Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.
;
Int J Urol; 2010 Oct; 17(10):830-8. PubMed ID: 20825509
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen best practice statement: 2009 update.
Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
[TBL] [Abstract][Full Text] [Related]
11. Health information styles among participants in a prostate cancer screening informed decision-making intervention.
Williams-Piehota PA; McCormack LA; Treiman K; Bann CM
Health Educ Res; 2008 Jun; 23(3):440-53. PubMed ID: 18385197
[TBL] [Abstract][Full Text] [Related]
12. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
[TBL] [Abstract][Full Text] [Related]
13. PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.
Otto SJ; Moss SM; Määttänen L; Roobol M; Zappa M; Nelen V; Kwiatkowski M; Villers A; Hugosson J; Sanchez AB; de Koning HJ
Eur J Cancer; 2010 Nov; 46(17):3053-60. PubMed ID: 21047586
[TBL] [Abstract][Full Text] [Related]
14. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
15. New PSA guidelines discourage overscreening.
Peres J
J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
[No Abstract] [Full Text] [Related]
16. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
[TBL] [Abstract][Full Text] [Related]
17. Should prostate-specific antigen screening be offered to asymptomatic men?
van Vugt HA; Bangma CH; Roobol MJ
Expert Rev Anticancer Ther; 2010 Jul; 10(7):1043-53. PubMed ID: 20645694
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
Kell JS
Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
[TBL] [Abstract][Full Text] [Related]
19. Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling.
Myers RE; Daskalakis C; Kunkel EJ; Cocroft JR; Riggio JM; Capkin M; Braddock CH
Patient Educ Couns; 2011 May; 83(2):240-6. PubMed ID: 20619576
[TBL] [Abstract][Full Text] [Related]
20. Use and assessment of PSA in prostate cancer.
Gjertson CK; Albertsen PC
Med Clin North Am; 2011 Jan; 95(1):191-200. PubMed ID: 21095422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
